New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free
ToolsComparePEG-MGF vs Thymulin

PEG-MGF vs Thymulin

Side-by-side comparison of key properties, dosing, and research.

Anabolic & IGF
PEG-MGF
Immune Support
Thymulin
Summary
PEG-MGF (Pegylated Mechano Growth Factor) is a modified form of MGF (Mechano Growth Factor) where polyethylene glycol (PEG) chains have been attached to extend its half-life from minutes to days. Native MGF is released locally in muscle in response to mechanical stress and quickly degrades. PEGylation allows systemic administration with sustained circulation, enabling whole-body muscle repair and anabolic signaling rather than the purely local effect of native MGF.
Thymulin is a nonapeptide hormone produced exclusively by the thymic epithelium. It requires zinc for biological activity and plays a critical role in T-lymphocyte maturation, differentiation, and immune regulation. Thymulin levels decline dramatically with age, contributing to immunosenescence.
Half-Life
~3 days (due to PEGylation)
~30 minutes active half-life
Admin Route
SubQ
SubQ
Research
Typical Dose
200–400 mcg
20-30 mcg
Frequency
2–3x per week
10 days per month (Khavinson protocol)
Key Benefits
  • Extended half-life (~3 days) vs native MGF (minutes)
  • Systemic muscle satellite cell activation via subcutaneous injection
  • Promotes muscle fiber repair and hypertrophy throughout the body
  • Enhanced recovery from intense training or muscle injury
  • Synergistic with IGF-1 LR3 and growth hormone peptides
  • Useful in sarcopenia, post-injury recovery, and athletic performance
  • Single injection provides multi-day anabolic signaling
  • Enhances T-cell maturation and differentiation
  • Boosts NK cell cytotoxic activity
  • Reduces inflammatory cytokine production (TNF-α, IL-1)
  • Anti-nociceptive (pain-reducing) properties
  • Restores age-related immune decline
  • Anti-inflammatory via serotonin pathway modulation
Side Effects
  • Water retention and localized swelling
  • Potential hypoglycemia at high doses
  • Theoretical cancer growth risk (growth factor)
  • Injection site reactions
  • +1 more
  • Injection site reactions
  • Mild fatigue initially as immune system activates
Stacks With